TRERF1 and neoplasm: Interestingly, consistent with other reports [20], RAPA decreased tumor angiogenesis, as reflected by reduced staining of the vasculature CD31 marker (Figure 4B), offering another possible mechanism underlying RAPA’s inhibition of immune cell infiltration and activation observed in this model.